Islet transplantation

Steady progress and current challenges

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose of review: Clinical islet transplantation has evolved rapidly in recent years and current clinical trials are showing the benefits of this therapeutic approach for patients with diabetes. New challenges are emerging and must be overcome in order to extend this therapeutic option to larger cohorts of patients who may benefit. This review summarizes the current state of clinical islet transplantation and progress made in translational research to address limitations. Recent findings: Transplantation of pancreatic islets has proven efficacy in improving metabolic control and quality of life, and in preventing severe hypoglycemia in patients with diabetes. New clinical islet transplant programs are being established worldwide and the annual number of transplants continues to increase. Recent improvements in pancreas procurement, islet isolation, and purification techniques have led to more consistent islet yields and better utilization of cadaveric donor pancreata. Improved methods for islet assessment are being developed to predict islet potency. A better understanding of the causes of islet dysfunction will be helpful in designing targeted interventions for islet cytoprotection and reducing the number of islets required to achieve insulin independence. Implementation of safer immunosuppressive/tolerogenic regimens will permit widespread application of islet transplantation to restore β-cell function in the future. Summary: The benefits of islet transplantation in managing patients with diabetes are tangible. Very encouraging data are emerging from the numerous clinical trials and from translational research ongoing worldwide that justify cautious optimism for the near future.

Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalCurrent Opinion in Organ Transplantation
Volume11
Issue number1
DOIs
StatePublished - Feb 1 2006

Fingerprint

Islets of Langerhans Transplantation
Translational Medical Research
Pancreas
Clinical Trials
Transplants
Cytoprotection
Immunosuppressive Agents
Hypoglycemia
Quality of Life
Tissue Donors
Insulin
Therapeutics

Keywords

  • Beta-cell replacement
  • Diabetes
  • Insulin
  • Islet transplantation

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Islet transplantation : Steady progress and current challenges. / Pileggi, Antonello; Alejandro, Rodolfo; Ricordi, Camillo.

In: Current Opinion in Organ Transplantation, Vol. 11, No. 1, 01.02.2006, p. 7-13.

Research output: Contribution to journalArticle

@article{1d45f124dad845dcb08e97570e265b3c,
title = "Islet transplantation: Steady progress and current challenges",
abstract = "Purpose of review: Clinical islet transplantation has evolved rapidly in recent years and current clinical trials are showing the benefits of this therapeutic approach for patients with diabetes. New challenges are emerging and must be overcome in order to extend this therapeutic option to larger cohorts of patients who may benefit. This review summarizes the current state of clinical islet transplantation and progress made in translational research to address limitations. Recent findings: Transplantation of pancreatic islets has proven efficacy in improving metabolic control and quality of life, and in preventing severe hypoglycemia in patients with diabetes. New clinical islet transplant programs are being established worldwide and the annual number of transplants continues to increase. Recent improvements in pancreas procurement, islet isolation, and purification techniques have led to more consistent islet yields and better utilization of cadaveric donor pancreata. Improved methods for islet assessment are being developed to predict islet potency. A better understanding of the causes of islet dysfunction will be helpful in designing targeted interventions for islet cytoprotection and reducing the number of islets required to achieve insulin independence. Implementation of safer immunosuppressive/tolerogenic regimens will permit widespread application of islet transplantation to restore β-cell function in the future. Summary: The benefits of islet transplantation in managing patients with diabetes are tangible. Very encouraging data are emerging from the numerous clinical trials and from translational research ongoing worldwide that justify cautious optimism for the near future.",
keywords = "Beta-cell replacement, Diabetes, Insulin, Islet transplantation",
author = "Antonello Pileggi and Rodolfo Alejandro and Camillo Ricordi",
year = "2006",
month = "2",
day = "1",
doi = "10.1097/01.mot.0000203878.00901.26",
language = "English",
volume = "11",
pages = "7--13",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Islet transplantation

T2 - Steady progress and current challenges

AU - Pileggi, Antonello

AU - Alejandro, Rodolfo

AU - Ricordi, Camillo

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Purpose of review: Clinical islet transplantation has evolved rapidly in recent years and current clinical trials are showing the benefits of this therapeutic approach for patients with diabetes. New challenges are emerging and must be overcome in order to extend this therapeutic option to larger cohorts of patients who may benefit. This review summarizes the current state of clinical islet transplantation and progress made in translational research to address limitations. Recent findings: Transplantation of pancreatic islets has proven efficacy in improving metabolic control and quality of life, and in preventing severe hypoglycemia in patients with diabetes. New clinical islet transplant programs are being established worldwide and the annual number of transplants continues to increase. Recent improvements in pancreas procurement, islet isolation, and purification techniques have led to more consistent islet yields and better utilization of cadaveric donor pancreata. Improved methods for islet assessment are being developed to predict islet potency. A better understanding of the causes of islet dysfunction will be helpful in designing targeted interventions for islet cytoprotection and reducing the number of islets required to achieve insulin independence. Implementation of safer immunosuppressive/tolerogenic regimens will permit widespread application of islet transplantation to restore β-cell function in the future. Summary: The benefits of islet transplantation in managing patients with diabetes are tangible. Very encouraging data are emerging from the numerous clinical trials and from translational research ongoing worldwide that justify cautious optimism for the near future.

AB - Purpose of review: Clinical islet transplantation has evolved rapidly in recent years and current clinical trials are showing the benefits of this therapeutic approach for patients with diabetes. New challenges are emerging and must be overcome in order to extend this therapeutic option to larger cohorts of patients who may benefit. This review summarizes the current state of clinical islet transplantation and progress made in translational research to address limitations. Recent findings: Transplantation of pancreatic islets has proven efficacy in improving metabolic control and quality of life, and in preventing severe hypoglycemia in patients with diabetes. New clinical islet transplant programs are being established worldwide and the annual number of transplants continues to increase. Recent improvements in pancreas procurement, islet isolation, and purification techniques have led to more consistent islet yields and better utilization of cadaveric donor pancreata. Improved methods for islet assessment are being developed to predict islet potency. A better understanding of the causes of islet dysfunction will be helpful in designing targeted interventions for islet cytoprotection and reducing the number of islets required to achieve insulin independence. Implementation of safer immunosuppressive/tolerogenic regimens will permit widespread application of islet transplantation to restore β-cell function in the future. Summary: The benefits of islet transplantation in managing patients with diabetes are tangible. Very encouraging data are emerging from the numerous clinical trials and from translational research ongoing worldwide that justify cautious optimism for the near future.

KW - Beta-cell replacement

KW - Diabetes

KW - Insulin

KW - Islet transplantation

UR - http://www.scopus.com/inward/record.url?scp=33644611982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644611982&partnerID=8YFLogxK

U2 - 10.1097/01.mot.0000203878.00901.26

DO - 10.1097/01.mot.0000203878.00901.26

M3 - Article

VL - 11

SP - 7

EP - 13

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 1

ER -